These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16213720)

  • 1. Conformationally restricted analogs of Combretastatin A-4 derived from SU5416.
    Li PK; Xiao Z; Hu Z; Pandit B; Sun Y; Sackett DL; Werbovetz K; Lewis A; Johnsamuel J
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5382-5. PubMed ID: 16213720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.
    Pandit B; Sun Y; Chen P; Sackett DL; Hu Z; Rich W; Li C; Lewis A; Schaefer K; Li PK
    Bioorg Med Chem; 2006 Oct; 14(19):6492-501. PubMed ID: 16860559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological studies of novel tubulin inhibitors.
    Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design.
    Sun L; Vasilevich NI; Fuselier JA; Hocart SJ; Coy DH
    Bioorg Med Chem Lett; 2004 May; 14(9):2041-6. PubMed ID: 15080975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
    Pettit GR; Toki BE; Herald DL; Boyd MR; Hamel E; Pettit RK; Chapuis JC
    J Med Chem; 1999 Apr; 42(8):1459-65. PubMed ID: 10212132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents.
    Dupeyre G; Chabot GG; Thoret S; Cachet X; Seguin J; Guénard D; Tillequin F; Scherman D; Koch M; Michel S
    Bioorg Med Chem; 2006 Jul; 14(13):4410-26. PubMed ID: 16529936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylthioindoles, potent inhibitors of tubulin polymerization.
    De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R
    J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4,5-Diaryl-3-aminopyrazole derivatives as analogs of Combretastatin A-4: synthesis and biological evaluation.
    Liu T; Cui R; Chen J; Zhang J; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2011 May; 344(5):279-86. PubMed ID: 21290430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice.
    Sun L; Vasilevich NI; Fuselier JA; Coy DH
    Anticancer Res; 2004; 24(1):179-86. PubMed ID: 15015595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of indole compounds derived from combretastatin A4: synthesis and biological screening of 5-phenylpyrrolo[3,4-a]carbazole-1,3-diones as potential antivascular agents.
    Ty N; Dupeyre G; Chabot GG; Seguin J; Quentin L; Chiaroni A; Tillequin F; Scherman D; Michel S; Cachet X
    Eur J Med Chem; 2010 Sep; 45(9):3726-39. PubMed ID: 20538383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues.
    Arthuis M; Pontikis R; Chabot GG; Quentin L; Scherman D; Florent JC
    Eur J Med Chem; 2011 Jan; 46(1):95-100. PubMed ID: 21112130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
    Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC
    ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors.
    Nakamura H; Kuroda H; Saito H; Suzuki R; Yamori T; Maruyama K; Haga T
    ChemMedChem; 2006 Jul; 1(7):729-40. PubMed ID: 16902927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents.
    Cushman M; Nagarathnam D; Gopal D; He HM; Lin CM; Hamel E
    J Med Chem; 1992 Jun; 35(12):2293-306. PubMed ID: 1613753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin.
    Bellina F; Cauteruccio S; Monti S; Rossi R
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5757-62. PubMed ID: 16950621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.
    Peifer C; Stoiber T; Unger E; Totzke F; Schächtele C; Marmé D; Brenk R; Klebe G; Schollmeyer D; Dannhardt G
    J Med Chem; 2006 Feb; 49(4):1271-81. PubMed ID: 16480264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.